27938482|t|Repetitive and Prolonged Omega-3 Fatty Acid Treatment After Traumatic Brain Injury Enhances Long-Term Tissue Restoration and Cognitive Recovery
27938482|a|Traumatic brain injury (TBI) is one of the most disabling clinical conditions that could lead to neurocognitive disorders in survivors. Our group and others previously reported that prophylactic enrichment of dietary omega-3 polyunsaturated fatty acids (n-3 PUFAs) markedly ameliorate cognitive deficits after TBI. However, it remains unclear whether a clinically relevant therapeutic regimen with n-3 PUFAs administered after TBI would still offer significant improvement of long-term cognitive recovery. In the present study, we employed the decline of spatial cognitive function as a main outcome after TBI to investigate the therapeutic efficacy of post - TBI n-3 PUFA treatment and the underlying mechanisms. Mice were subjected to sham operation or controlled cortical impact, followed by random assignment to receive the following four treatments: (1) vehicle control; (2) daily intraperitoneal injections of n-3 PUFAs for 2 weeks, beginning 2 h after TBI; (3) fish oil dietary supplementation throughout the study, beginning 1 day after TBI; or (4) combination of treatments (2) and (3). Spatial cognitive deficits and chronic brain tissue loss, as well as endogenous brain repair processes such as neurogenesis, angiogenesis, and oligodendrogenesis, were evaluated up to 35 days after TBI. The results revealed prominent spatial cognitive deficits and massive tissue loss caused by TBI. Among all mice receiving post-TBI n-3 PUFA treatments, the combined treatment of fish oil dietary supplement and n-3 PUFA injections demonstrated a reproducible beneficial effect in attenuating cognitive deficits although without reducing gross tissue loss. Mechanistically, the combined treatment promoted post-TBI restorative processes in the brain, including generation of immature neurons, microvessels, and oligodendrocytes, each of which was significantly correlated with the improved cognitive recovery. These results indicated that repetitive and prolonged n-3 PUFA treatments after TBI are capable of enhancing brain remodeling and could be developed as a potential therapy to treat TBI victims in the clinic.
27938482	0	10	Repetitive	T079	C2945760
27938482	15	24	Prolonged	T079	C0439590
27938482	25	43	Omega-3 Fatty Acid	T109,T121,T123	C0015689
27938482	44	53	Treatment	T061	C0087111
27938482	54	59	After	T079	C0687676
27938482	60	82	Traumatic Brain Injury	T037	C0876926
27938482	83	91	Enhances	T052	C2349975
27938482	92	101	Long-Term	T079	C0443252
27938482	102	108	Tissue	T024	C0040300
27938482	109	120	Restoration	T061	C0087111
27938482	125	143	Cognitive Recovery	T061	C0009244
27938482	144	166	Traumatic brain injury	T037	C0876926
27938482	168	171	TBI	T037	C0876926
27938482	192	221	disabling clinical conditions	T033	C4061999
27938482	233	237	lead	T169	C1522538
27938482	241	265	neurocognitive disorders	T048	C4041080
27938482	269	278	survivors	T101	C0206194
27938482	284	289	group	T098	C1705429
27938482	294	300	others	T098	C1257890
27938482	312	320	reported	T170	C0684224
27938482	326	349	prophylactic enrichment	T061	C0199176
27938482	353	360	dietary	T169	C2699635
27938482	361	396	omega-3 polyunsaturated fatty acids	T109,T121,T123	C0015689
27938482	398	407	n-3 PUFAs	T109,T121,T123	C0015689
27938482	418	428	ameliorate	T169	C0332303
27938482	429	447	cognitive deficits	T048	C0009241
27938482	448	453	after	T079	C0687676
27938482	454	457	TBI	T037	C0876926
27938482	479	486	unclear	T033	C3845108
27938482	497	507	clinically	T080	C0443178
27938482	508	516	relevant	T080	C2347946
27938482	517	536	therapeutic regimen	T061	C1276413
27938482	542	551	n-3 PUFAs	T109,T121,T123	C0015689
27938482	552	564	administered	T169	C1521801
27938482	565	570	after	T079	C0687676
27938482	571	574	TBI	T037	C0876926
27938482	605	616	improvement	T077	C2986411
27938482	620	629	long-term	T079	C0443252
27938482	630	648	cognitive recovery	T061	C0009244
27938482	665	670	study	T062	C2603343
27938482	688	695	decline	T080	C1511741
27938482	707	725	cognitive function	T048	C0009241
27938482	731	735	main	T080	C1542147
27938482	736	743	outcome	T169	C1274040
27938482	744	749	after	T079	C0687676
27938482	750	753	TBI	T037	C0876926
27938482	757	768	investigate	T169	C1292732
27938482	773	793	therapeutic efficacy	T080	C2348767
27938482	797	801	post	T079	C0687676
27938482	804	807	TBI	T037	C0876926
27938482	808	816	n-3 PUFA	T109,T121,T123	C0015689
27938482	817	826	treatment	T061	C0087111
27938482	846	856	mechanisms	T169	C0441712
27938482	858	862	Mice	T015	C0025929
27938482	881	895	sham operation	T061	C0141287
27938482	899	909	controlled	T169	C2587213
27938482	910	918	cortical	T023	C0007776
27938482	919	925	impact	T080	C4049986
27938482	939	956	random assignment	UnknownType	C0814868
27938482	960	967	receive	T080	C1514756
27938482	982	986	four	T081	C0205450
27938482	987	997	treatments	T061	C0087111
27938482	1003	1010	vehicle	T122	C0042444
27938482	1011	1018	control	T169	C2587213
27938482	1024	1029	daily	T079	C0332173
27938482	1030	1056	intraperitoneal injections	T061	C0021493
27938482	1060	1069	n-3 PUFAs	T109,T121,T123	C0015689
27938482	1076	1081	weeks	T079	C0439230
27938482	1083	1092	beginning	T079	C0439659
27938482	1095	1096	h	T079	C0439227
27938482	1097	1102	after	T079	C0687676
27938482	1103	1106	TBI	T037	C0876926
27938482	1112	1128	fish oil dietary	T168	C0556145
27938482	1129	1144	supplementation	T061	C0242297
27938482	1160	1165	study	T062	C2603343
27938482	1167	1176	beginning	T079	C0439659
27938482	1179	1182	day	T079	C0439228
27938482	1183	1188	after	T079	C0687676
27938482	1189	1192	TBI	T037	C0876926
27938482	1201	1212	combination	T080	C0205195
27938482	1216	1226	treatments	T061	C0087111
27938482	1271	1278	chronic	T079	C0205191
27938482	1279	1291	brain tissue	T023	C0459385
27938482	1292	1296	loss	T081	C1517945
27938482	1309	1319	endogenous	T169	C0205227
27938482	1320	1342	brain repair processes	T061	C0161849
27938482	1351	1363	neurogenesis	T040	C0814002
27938482	1365	1377	angiogenesis	T042	C0302600
27938482	1383	1401	oligodendrogenesis	T038	C3714634
27938482	1427	1431	days	T079	C0439228
27938482	1432	1437	after	T079	C0687676
27938482	1438	1441	TBI	T037	C0876926
27938482	1447	1454	results	T169	C1274040
27938482	1455	1463	revealed	T080	C0443289
27938482	1482	1500	cognitive deficits	T048	C0009241
27938482	1505	1512	massive	T080	C0522501
27938482	1513	1519	tissue	T023	C0459385
27938482	1520	1524	loss	T081	C1517945
27938482	1535	1538	TBI	T037	C0876926
27938482	1550	1554	mice	T015	C0025929
27938482	1555	1564	receiving	T080	C1514756
27938482	1565	1573	post-TBI	T037	C0876926
27938482	1574	1582	n-3 PUFA	T109,T121,T123	C0015689
27938482	1583	1593	treatments	T061	C0087111
27938482	1599	1607	combined	T080	C0205195
27938482	1608	1617	treatment	T061	C0087111
27938482	1621	1637	fish oil dietary	T168	C0556145
27938482	1638	1648	supplement	T168	C0242295
27938482	1653	1661	n-3 PUFA	T109,T121,T123	C0015689
27938482	1662	1672	injections	T122	C1272883
27938482	1673	1685	demonstrated	T052	C3687625
27938482	1688	1718	reproducible beneficial effect	UnknownType	C0683156
27938482	1734	1752	cognitive deficits	T048	C0009241
27938482	1770	1778	reducing	T080	C0392756
27938482	1779	1784	gross	T080	C0439806
27938482	1785	1791	tissue	T023	C0459385
27938482	1792	1796	loss	T081	C1517945
27938482	1828	1837	treatment	T061	C0087111
27938482	1838	1846	promoted	T052	C0033414
27938482	1847	1855	post-TBI	T037	C0876926
27938482	1856	1877	restorative processes	T061	C0541662
27938482	1885	1890	brain	T023	C0006104
27938482	1892	1901	including	T169	C0332257
27938482	1916	1932	immature neurons	T025	C0027882
27938482	1934	1946	microvessels	T023	C2350570
27938482	1952	1968	oligodendrocytes	T025	C0028944
27938482	2002	2012	correlated	T080	C1707520
27938482	2022	2030	improved	T033	C0184511
27938482	2031	2049	cognitive recovery	T169	C1274040
27938482	2057	2064	results	T169	C1274040
27938482	2065	2074	indicated	T033	C1444656
27938482	2080	2090	repetitive	T079	C2945760
27938482	2095	2104	prolonged	T079	C0439590
27938482	2105	2113	n-3 PUFA	T109,T121,T123	C0015689
27938482	2114	2124	treatments	T061	C0087111
27938482	2125	2130	after	T079	C0687676
27938482	2131	2134	TBI	T037	C0876926
27938482	2150	2159	enhancing	T052	C2349975
27938482	2160	2165	brain	T023	C0006104
27938482	2166	2176	remodeling	UnknownType	C0678692
27938482	2205	2214	potential	T080	C3245505
27938482	2215	2222	therapy	T061	C0087111
27938482	2232	2235	TBI	T037	C0876926
27938482	2236	2243	victims	T098	C0680681
27938482	2251	2257	clinic	T073,T093	C0442592